The pharmaceutical company said it can manufacture 120 million packs but has only sold 50 million, leaving room for 70 million to be stuffed in reserve, according to Airfinity’s estimates.
Pfizer earned $1.5 billion in 2022’s first quarter thanks to Paxlovid, about five months after its launch, according to the company. Airfinity said this number is expected to increase sales revenue by 530 percent, to $9.3 billion, by the second quarter.
Despite Airfinity’s forecasts predicting Paxlovid to take nearly 80 percent of the antiviral market share, sales are leveling off. This may be because of staffing shortages, pharmacy deserts or the controversial FDA decision to allow pharmacists to prescribe the treatment.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
